Variant report
Variant | esv3444726 |
---|---|
Chromosome Location | chr5:68928996-68932094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:57)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr5:68929807-68929986 | GM12878 | blood: | n/a | n/a |
2 | CTCF | chr5:68929341-68929391 | Kidney_OC | kidney: | n/a | n/a |
3 | FOSL2 | chr5:68929549-68929799 | HepG2 | liver: | n/a | n/a |
4 | FOXP2 | chr5:68930535-68930850 | PFSK-1 | brain: | n/a | n/a |
5 | FOXP2 | chr5:68929029-68929480 | PFSK-1 | brain: | n/a | n/a |
6 | FOXP2 | chr5:68929790-68930211 | PFSK-1 | brain: | n/a | n/a |
7 | GABPA | chr5:68930033-68930246 | Hela-S3 | cervix: | n/a | n/a |
8 | GABPA | chr5:68929617-68929721 | Hela-S3 | cervix: | n/a | n/a |
9 | GABPA | chr5:68929546-68929739 | Hela-S3 | cervix: | n/a | n/a |
10 | GABPA | chr5:68930007-68930160 | Hela-S3 | cervix: | n/a | n/a |
11 | GABPA | chr5:68930359-68930595 | Hela-S3 | cervix: | n/a | n/a |
12 | JUND | chr5:68930384-68930620 | HepG2 | liver: | n/a | n/a |
13 | PAX5 | chr5:68930365-68930625 | GM12878 | blood: | n/a | n/a |
14 | PAX5 | chr5:68930331-68930663 | GM12878 | blood: | n/a | n/a |
15 | PAX5 | chr5:68931176-68931370 | GM12878 | blood: | n/a | n/a |
16 | PAX5 | chr5:68930014-68930176 | GM12878 | blood: | n/a | n/a |
17 | PAX5 | chr5:68929552-68929761 | GM12878 | blood: | n/a | n/a |
18 | PBX3 | chr5:68929846-68929968 | GM12878 | blood: | n/a | n/a |
19 | PBX3 | chr5:68929623-68929726 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr5:68931184-68931438 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr5:68930369-68930618 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | POLR2A | chr5:68931158-68931952 | GM12878 | blood: | n/a | n/a |
23 | POLR2A | chr5:68928572-68930676 | GM12892 | blood: | n/a | n/a |
24 | POLR2A | chr5:68931168-68931379 | GM12878 | blood: | n/a | n/a |
25 | POLR2A | chr5:68930383-68930609 | GM12878 | blood: | n/a | n/a |
26 | POLR2A | chr5:68929180-68929364 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | POLR2A | chr5:68931081-68931809 | GM12892 | blood: | n/a | n/a |
28 | POLR2A | chr5:68928580-68930732 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr5:68930356-68930589 | GM12878 | blood: | n/a | n/a |
30 | POLR2A | chr5:68930068-68930751 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | POLR2A | chr5:68929543-68929786 | GM12878 | blood: | n/a | n/a |
32 | POLR2A | chr5:68930379-68930618 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | POLR2A | chr5:68929979-68930181 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr5:68931380-68931798 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr5:68928560-68930691 | GM12892 | blood: | n/a | n/a |
36 | POLR2A | chr5:68929566-68929783 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | POLR2A | chr5:68928867-68929722 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | POLR2A | chr5:68929989-68930177 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | POLR2A | chr5:68928623-68929482 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr5:68929546-68929800 | H1-hESC | embryonic stem cell: | n/a | n/a |
41 | POLR2A | chr5:68929228-68929431 | GM12878 | blood: | n/a | n/a |
42 | POU2F2 | chr5:68930384-68930500 | GM12878 | blood: | n/a | n/a |
43 | POU2F2 | chr5:68929160-68929457 | GM12878 | blood: | n/a | n/a |
44 | POU2F2 | chr5:68931392-68931857 | GM12878 | blood: | n/a | n/a |
45 | POU2F2 | chr5:68931228-68931360 | GM12878 | blood: | n/a | n/a |
46 | POU2F2 | chr5:68930336-68930653 | GM12878 | blood: | n/a | n/a |
47 | POU2F2 | chr5:68929615-68929729 | GM12878 | blood: | n/a | n/a |
48 | POU2F2 | chr5:68929523-68930102 | GM12878 | blood: | n/a | n/a |
49 | REST | chr5:68931160-68931784 | SK-N-SH | brain: | n/a | n/a |
50 | SPI1 | chr5:68929545-68929737 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250138 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200447535 | chr5:68929006-68929007 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs201113383 | chr5:68929009-68929010 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs200967433 | chr5:68929011-68929012 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs200704023 | chr5:68929013-68929014 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs377581375 | chr5:68929078-68929079 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs201180084 | chr5:68929117-68929118 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs199643856 | chr5:68929118-68929119 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs531627218 | chr5:68929152-68929153 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs550061259 | chr5:68929157-68929158 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs370554522 | chr5:68929168-68929169 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs111743460 | chr5:68929183-68929184 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs368257592 | chr5:68929196-68929197 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs200653071 | chr5:68929265-68929266 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs553849760 | chr5:68929270-68929271 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs565626034 | chr5:68929306-68929307 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs111447363 | chr5:68929320-68929321 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs201812412 | chr5:68929326-68929327 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs539450661 | chr5:68929328-68929329 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs374743415 | chr5:68929329-68929330 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs557319879 | chr5:68929347-68929348 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs200146773 | chr5:68929352-68929353 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs200719742 | chr5:68929360-68929361 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs537350175 | chr5:68929378-68929379 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs201734951 | chr5:68929392-68929393 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs199882730 | chr5:68929399-68929400 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs541248258 | chr5:68929413-68929414 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs112630804 | chr5:68929424-68929425 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs202103042 | chr5:68929485-68929486 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs200049018 | chr5:68929505-68929506 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs201029296 | chr5:68929552-68929553 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs375068468 | chr5:68929568-68929569 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs202132524 | chr5:68929600-68929601 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs200518621 | chr5:68929614-68929615 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs201195210 | chr5:68929619-68929620 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs201783816 | chr5:68929627-68929628 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs545460206 | chr5:68929644-68929645 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs563682488 | chr5:68929647-68929648 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs530881863 | chr5:68929671-68929672 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs550122167 | chr5:68929695-68929696 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs561801727 | chr5:68929706-68929707 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs200240129 | chr5:68929707-68929708 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs201285948 | chr5:68929714-68929715 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs529122602 | chr5:68929718-68929719 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs547256463 | chr5:68929722-68929723 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs565817071 | chr5:68929743-68929744 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs539154347 | chr5:68929745-68929746 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs551012944 | chr5:68929759-68929760 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 21865298 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
Disease | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68926600-68929000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr5:68926600-68929000 | Weak transcription | Primary T cells from cord blood | blood |
3 | chr5:68926600-68929000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:68926600-68929000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr5:68926600-68929000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
6 | chr5:68926600-68929000 | Weak transcription | Brain Germinal Matrix | brain |
7 | chr5:68926600-68929000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
8 | chr5:68926600-68929000 | Weak transcription | Fetal Intestine Large | intestine |
9 | chr5:68926600-68929000 | Weak transcription | Fetal Intestine Small | intestine |
10 | chr5:68926600-68929000 | Weak transcription | Fetal Stomach | stomach |
11 | chr5:68926600-68929000 | Weak transcription | Ovary | ovary |
12 | chr5:68928200-68929800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |